Edition:
United States

Profile: Atcor Medical Holdings Ltd (ACG.AX)

ACG.AX on Australia Stock Exchange

0.06AUD
6 Dec 2016
Change (% chg)

-- (--)
Prev Close
$0.06
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
426,986
52-wk High
$0.23
52-wk Low
$0.06

AtCor Medical Holdings Ltd is engaged in the designing, manufacturing and marketing of medical devices for use in cardiovascular management. The Company operates through three segments: Americas, which includes global pharmaceutical trials business; Europe, which includes Middle East and Africa, and Asia Pacific, which includes Asia and Australia/New Zealand. The Company's clinical trial services, include study protocol assistance, study-specific user manual, operator training and certification, study-specific training materials, automated data transfer for expert over-read, quality assurance, ongoing data management, technical support and sponsor-defined data transfers. The Company also offers SphygmoCor technology, which is used in clinical trials for a range of therapeutic areas, including hypertension, renal disease, heart failure, inflammatory processes, diabetes and chronic obstructive pulmonary disease (COPD).

Company Address

Atcor Medical Holdings Ltd

U 11 1059 Victoria Rd
SYDNEY   NSW   2114

Company Web Links